Trials / No Longer Available
No Longer AvailableNCT04465929
Expanded Access - Autologous Human Schwann Cells in Peripheral Nerve Repair
Expanded Access - The Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation of Nerve Autografts After Severe Peripheral Nerve Injury (PNI)
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- W. Dalton Dietrich · Academic / Other
- Sex
- Female
- Age
- 16 Years – 16 Years
- Healthy volunteers
- —
Summary
Emergency expanded access for a single patient was granted to receive autologous human Schwann cell (ahSC) augmentation of nerve autograft repair after severe peripheral nerve injury (PNI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Human Schwann Cells | Schwann cells harvested from the sural nerve and debrided, injured sciatic nerve of the participant will be autologously transplanted along sural nerve autografts wrapped in a collagen matrix |
Timeline
- First posted
- 2020-07-10
- Last updated
- 2020-07-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04465929. Inclusion in this directory is not an endorsement.